Professor and Chief, Division of Surgical Oncology University of Rochester Rochester, New York, United States
Disclosure(s):
Darren R. Carpizo, MD, PhD: No financial relationships to disclose
Multiple technologies are now available and being used to measure circulating tumor DNA in our patients. The purpose of this session is to understand how these work, the most recent data on their use for advanced colon cancer and pancreatic cancers, what the results mean, and how they can provide guidance on surgical decisions and timing of surgery.
